Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

Keyphrases

• Mortality Risk 100%
• Metformin 100%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Sulfonylurea 100%
• Adverse Cardiovascular Events 100%
• Relative Risk 37%
• Cardiovascular Mortality 37%
• Scotland 25%
• Diabetes 25%
• Tayside 25%
• Oral Hypoglycemic Agents 25%
• Cardiovascular Hospital Admissions 25%
• Special Characters 12%
• Blood Pressure 12%
• Between-group 12%
• Cholesterol 12%
• All-cause Mortality 12%
• Hospital Admission 12%
• High Risk 12%
• Monitoring System 12%
• Type 2 Diabetic Patients 12%
• Cox Regression Analysis 12%
• Metformin Monotherapy 12%
• Cardiovascular Medications 12%
• Diabetes Duration 12%
• HBA1 12%

Medicine and Dentistry

• Maturity Onset Diabetes of the Young 100%
• Glycon 100%
• Cardiovascular System 100%
• Sulfonylurea 100%
• Diabetes 37%
• Cohort Analysis 37%
• Cardiovascular Mortality 37%
• Oral Antidiabetic Agent 25%
• Polyacrylamide Gel Electrophoresis 12%
• Blood Pressure 12%
• Medicine 12%
• Patient with Type 2 Diabetes 12%
• Proportional Hazards Model 12%
• All Cause Mortality 12%
• Monotherapy 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Metformin 100%
• Sulfonylurea 100%
• Non Insulin Dependent Diabetes Mellitus 100%
• Cohort Study 37%
• Cardiovascular Mortality 37%
• Oral Antidiabetic Agent 25%
• Polyacrylamide Gel Electrophoresis 12%
• All Cause Mortality 12%
• Monotherapy 12%